- To provide tools to monitor the development of health technologies and to share data and results of this monitoring. Only aggregated or anonymised data will be used
- To structure prioritisation for HTA and provide health care decision makers with policy relevant information on new and emerging technologies.
- A tool to monitor emerging technologies in clinical practice with insufficient evidence of clinical or cost effectiveness
- A structured information service on high volume, costly, rapidly developing, emerging technology Strand B, closely coordinated with WP2 and WP6.
French National Authority for Health (Haute Autorité de Santé)
5, avenue du Stade de France
F-93218 Saint-Denis La Plaine Cedex